Literature DB >> 17554697

Microbial colonization of the upper gastrointestinal tract in patients with Barrett's esophagus.

Sandra Macfarlane1, Elizabeth Furrie, George T Macfarlane, John F Dillon.   

Abstract

BACKGROUND: Barrett's esophagus (BE) is a complication of chronic gastroesophageal reflux disease, in which patients are at greatly increased risk of esophageal dysplasia and adenocarcinoma. Over the past 2 decades, there has been an increase in the incidence of both BE and adenocarcinoma; however, the involvement of microorganisms in BE is uncertain. The aim of this study was to characterize microbial communities in esophageal aspirate specimens and on distal esophageal mucosal samples from patients with BE.
METHODS: Biopsy and aspirate specimens were obtained by endoscopic examination from 7 patients with BE and 7 control subjects without BE. Samples were cultured under aerobic, anaerobic, and microaerophilic conditions for yeasts and bacteria, including Helicobacter pylori. Bacterial isolates were identified by 16S ribosomal RNA gene sequencing. Fluorescence microscopic examination was also used to determine the spatial localization of these organisms on mucosal surfaces. Significant colonization was detected in 6 patients with BE and in 4 control subjects.
RESULTS: Overall, 46 bacterial species belonging to 16 genera were detected, with 10 species being common in both groups. Both aspirate and biopsy samples from patients with BE contained complex populations of bacteria. Uniquely, high levels of Campylobacter species (Campylobacter concisus and Campylobacter rectus), which have been linked to enteritis, periodontal infections, and tumor formation in animals, were found in 4 (57%) of 7 patients with BE but in none of the control subjects. Microscopic examination revealed that bacteria on mucosal biofilms often occurred in microcolonies.
CONCLUSIONS: The occurrence of nitrate-reducing Campylobacter species in patients with BE may suggest that there is a link in either the initiation, maintenance, or exacerbation of disease processes leading to adenocarcinoma formation.

Entities:  

Mesh:

Year:  2007        PMID: 17554697     DOI: 10.1086/518578

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  57 in total

1.  Functional relationship between Campylobacter concisus and the stomach ecosystem in health and disease.

Authors:  Nadeem O Kaakoush; Si Ming Man; Hazel M Mitchell
Journal:  ISME J       Date:  2013-07-04       Impact factor: 10.302

Review 2.  Emerging roles of the microbiome in cancer.

Authors:  Scott J Bultman
Journal:  Carcinogenesis       Date:  2013-12-03       Impact factor: 4.944

Review 3.  Microbiome in reflux disorders and esophageal adenocarcinoma.

Authors:  Liying Yang; Noami Chaudhary; Jonathan Baghdadi; Zhiheng Pei
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

Review 4.  Global Epidemiology of Campylobacter Infection.

Authors:  Nadeem O Kaakoush; Natalia Castaño-Rodríguez; Hazel M Mitchell; Si Ming Man
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 5.  Microbial biofilms and gastrointestinal diseases.

Authors:  Erik C von Rosenvinge; Graeme A O'May; Sandra Macfarlane; George T Macfarlane; Mark E Shirtliff
Journal:  Pathog Dis       Date:  2013-01-29       Impact factor: 3.166

Review 6.  The Esophageal Microbiome in Health and Disease.

Authors:  Brooke Corning; Andrew P Copland; Jeanetta W Frye
Journal:  Curr Gastroenterol Rep       Date:  2018-08-01

7.  Dysbiosis of the gut microbiome is associated with thyroid cancer and thyroid nodules and correlated with clinical index of thyroid function.

Authors:  Jiaming Zhang; Fanghua Zhang; Changying Zhao; Qian Xu; Cheng Liang; Ying Yang; Huiling Wang; Yongfang Shang; Ye Wang; Xiaofeng Mu; Dequan Zhu; Chunling Zhang; Junjie Yang; Minxiu Yao; Lei Zhang
Journal:  Endocrine       Date:  2018-12-24       Impact factor: 3.633

8.  Transcriptomic and proteomic analyses reveal key innate immune signatures in the host response to the gastrointestinal pathogen Campylobacter concisus.

Authors:  Nadeem O Kaakoush; Nandan P Deshpande; Si Ming Man; Jose A Burgos-Portugal; Faisal A Khattak; Mark J Raftery; Marc R Wilkins; Hazel M Mitchell
Journal:  Infect Immun       Date:  2014-12-08       Impact factor: 3.441

Review 9.  Upper gastrointestinal microbiota and digestive diseases.

Authors:  Zi-Kai Wang; Yun-Sheng Yang
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

Review 10.  Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.

Authors:  Antonio Galvao Neto; April Whitaker; Zhiheng Pei
Journal:  Semin Oncol       Date:  2015-09-07       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.